Equity Analyst Upgrades and Downgrades You Must Know May 8th

Wall St. Watchdog reveals information about companies for which stock analysts either upgraded or downgraded the shares on May 8th.

Upgrades

Veeco Instruments (NASDAQ:VECO):

Barclays upgraded its rating on this company from Equal Weight to Overweight and changed its price target from $34 to $45.

Stamps.com (NASDAQ:STMP):

Northland Securities upgraded its rating on this company from Market Perform to Outperform and changed its price target to $32.

Exco Resources (NYSE:XCO):

KeyBanc Capital Mkts upgraded its rating on this company from Hold to Buy and changed its price target to $10.

Cimarex (NYSE:XEC):

Canaccord Genuity upgraded its rating on this company from Hold to Buy and changed its price target to $84.

Capital One (NYSE:COF):

Argus upgraded its rating on this company from Sell to Hold.

NYSE Euronext (NYSE:NYX):

Stifel Nicolaus upgraded its rating on this company from Sell to Hold.

American Science & Engineering (NASDAQ:ASEI):

The Benchmark Company upgraded its rating on this company from Sell to Hold and changed its price target to $66.

Vertex Pharm (NASDAQ:VRTX):

Needham upgraded its rating on this company from Hold to Buy and changed its price target to $65.

Electronic Arts (NASDAQ:EA):

Needham upgraded its rating on this company from Hold to Buy and changed its price target to $22.

National Retail Properties (NYSE:NNN):

FBR Capital upgraded its rating on this company from Mkt Perform to Outperform and changed its price target from $27 to $30.

Cognizant Tech (NASDAQ:CTSH):

Robert W. Baird upgraded its rating on this company from Neutral to Outperform and changed its price target to $76.

Downgrades

Callon Petroleum (NYSE:CPE):

Howard Weil downgraded its rating on this company from Market Outperform to Market Perform and changed its price target from $10 to $8.

Marathon Oil (NYSE:MRO):

Howard Weil downgraded its rating on this company from Focus Stock to Market Outperform and changed its price target from $39 to $33.

Affymax (NASDAQ:AFFY):

WBB Securities downgraded its rating on this company from Strong Buy to Buy and changed its price target from $9 to $17.

MAKO Surgical (NASDAQ:MAKO):

Mizuho downgraded its rating on this company from Buy to Neutral and changed its price target from $54 to $30.

Thomas & Betts (NYSE:TNB):

Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target to $72.

National Cinemedia (NASDAQ:NCMI):

Imperial Capital downgraded its rating on this company from Outperform to In-line and changed its price target from $16 to $14.5.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.